XML 32 R23.htm IDEA: XBRL DOCUMENT v3.22.2.2
Strategic Transformation (Tables)
6 Months Ended
Jun. 30, 2022
Discontinued Operations and Disposal Groups [Abstract]  
Summary of Results of Discontinued Operations and Class of Assets and Liabilities

The following table presents the combined results of discontinued operations of the Laboratory Operations (in thousands):

 

 

Three Months Ended
June 30,

 

 

Six Months Ended
June 30,

 

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

Revenues

 

$

759

 

 

$

18,242

 

 

$

2,027

 

 

$

42,601

 

Cost of sales

 

 

 

 

 

26,233

 

 

 

 

 

 

48,466

 

Gross profit (loss)

 

 

759

 

 

 

(7,991

)

 

 

2,027

 

 

 

(5,865

)

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

 

 

 

 

1,590

 

 

 

 

 

 

1,590

 

Selling and marketing

 

 

 

 

 

20,127

 

 

 

 

 

 

32,917

 

General and administrative

 

 

275

 

 

 

7,413

 

 

 

861

 

 

 

11,533

 

Total operating expenses

 

 

275

 

 

 

29,130

 

 

 

861

 

 

 

46,040

 

Other expense, net

 

 

 

 

 

(10

)

 

 

 

 

 

(29

)

Loss from discontinued operations before income taxes

 

 

484

 

 

 

(37,131

)

 

 

1,166

 

 

 

(51,934

)

Income tax benefit

 

 

 

 

 

 

 

 

 

 

 

 

Net gain (loss) from discontinued operations

 

$

484

 

 

$

(37,131

)

 

$

1,166

 

 

$

(51,934

)

The following table presents the carrying amounts of the remaining assets held for sale related to the Laboratory Operations as of June 30, 2022 and December 31, 2021 (in thousands):

 

 

June 30,
2022

 

 

December 31,
2021

 

 

 

 

 

 

 

 

Current assets of disposal group held for sale

 

 

 

 

 

 

Property and equipment, net

 

 

2,147

 

 

 

2,147

 

Total current assets of disposal group held for sale (1)

 

$

2,147

 

 

$

2,147

 

 

(1) The remaining assets of the Laboratory Operations are classified as held for sale and are classified as current in the unaudited condensed consolidated balance sheet at June 30, 2022 and December 31, 2021, because they are expected to be sold within one year.